<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="pt" article-type="editorial"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq Bras Cardiol</journal-id><journal-id journal-id-type="publisher-id">abc</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40298743</article-id><article-id pub-id-type="pmc">PMC12094289</article-id>
<article-id pub-id-type="other">00209</article-id><article-id pub-id-type="doi">10.36660/abc.20250085</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minieditorial</subject></subj-group></article-categories><title-group><article-title>Tecnologias para Melhor Controle Press&#x000f3;rico: Os Aplicativos Oferecem a Qualidade Necess&#x000e1;ria?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1582-7268</contrib-id><name><surname>Miranda</surname><given-names>Roberto Dischinger</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-9895-3056</contrib-id><name><surname>Laurindo</surname><given-names>Bruna de Oliveira</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-2921-1559</contrib-id><name><surname>Licco</surname><given-names>Maria Eduarda Augusto</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff1">
<label>1</label>
<institution content-type="orgname">Universidade Federal de S&#x000e3;o Paulo</institution>
<institution content-type="orgdiv1">Servi&#x000e7;o de Cardiologia</institution>
<institution content-type="orgdiv2">Disciplina de Geriatria e Gerontologia</institution>
<addr-line>
<named-content content-type="city">S&#x000e3;o Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Servi&#x000e7;o de Cardiologia, Disciplina de Geriatria e Gerontologia, Escola Paulista de Medicina da Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP &#x02013; Brasil</institution>
</aff></contrib-group><author-notes><corresp id="c1">
<label>Correspond&#x000ea;ncia:</label>
<bold>Roberto Dischinger Miranda</bold>
&#x02022; Servi&#x000e7;o de Cardiologia, Disciplina de Geriatria e Gerontologia, Escola Paulista de Medicina da Universidade Federal de S&#x000e3;o Paulo - R. dos Otonis, 863. CEP
<postal-code>04025-002</postal-code>
, S&#x000e3;o Paulo, SP - Brasil E-mail:
<email>roberto.miranda@institutolongevita.com.br</email>
</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>122</volume><issue>2</issue><elocation-id>e20250085</elocation-id><history><date date-type="received"><day>04</day><month>2</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>2</month><year>2025</year></date></history><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p></license></permissions><kwd-group><title>Palavras-chave</title><kwd>Aplicativos M&#x000f3;veis</kwd><kwd>Tecnologia</kwd><kwd>Smartphone</kwd><kwd>Hipertens&#x000e3;o</kwd><kwd>Hipertens&#x000e3;o Essencial</kwd><kwd>Ades&#x000e3;o &#x000e0; Medica&#x000e7;&#x000e3;o</kwd></kwd-group><counts><fig-count count="4"/><table-count count="0"/><equation-count count="0"/><ref-count count="10"/></counts></article-meta></front><body><p>As doen&#x000e7;as cr&#x000f4;nicas s&#x000e3;o altamente prevalentes entre a popula&#x000e7;&#x000e3;o adulta brasileira, com tend&#x000ea;ncia a aumentar nos pr&#x000f3;ximos anos devido, principalmente, ao envelhecimento populacional. Dentre elas, se destaca a hipertens&#x000e3;o arterial sist&#x000ea;mica (HA), que acomete cerca de 27,9% dos brasileiros. Essa condi&#x000e7;&#x000e3;o &#x000e9; o principal fator de risco modific&#x000e1;vel para doen&#x000e7;as cardiovasculares, doen&#x000e7;a renal cr&#x000f4;nica e morte prematura, sendo que em 2021 a taxa de mortalidade por HA atingiu o maior valor dos &#x000fa;ltimos dez anos, com a ocorr&#x000ea;ncia de 18,7 &#x000f3;bitos por 100 mil habitantes.<sup>
<xref rid="B1" ref-type="bibr">1</xref>
,
<xref rid="B2" ref-type="bibr">2</xref>
</sup></p><p>Entre os desafios para o controle da HA, se encontra o fato de ser uma condi&#x000e7;&#x000e3;o assintom&#x000e1;tica, o que dificulta a ades&#x000e3;o ao tratamento, que inclui mudan&#x000e7;as no estilo de vida e o uso regular das medica&#x000e7;&#x000f5;es anti-hipertensivas. &#x000c9; estimado que, entre os pacientes hipertensos, menos da metade use as medica&#x000e7;&#x000f5;es adequadamente, sendo que a m&#x000e1; ades&#x000e3;o medicamentosa foi declarada pela Organiza&#x000e7;&#x000e3;o Mundial de Sa&#x000fa;de como um problema de sa&#x000fa;de p&#x000fa;blica. Dentre as causas da m&#x000e1; ades&#x000e3;o, est&#x000e3;o relatadas a falta de educa&#x000e7;&#x000e3;o em sa&#x000fa;de, a aus&#x000ea;ncia de percep&#x000e7;&#x000e3;o de melhora com uso da medica&#x000e7;&#x000e3;o, a ocorr&#x000ea;ncia de efeitos adversos e o esquecimento quanto ao uso das medica&#x000e7;&#x000f5;es.<sup>
<xref rid="B3" ref-type="bibr">3</xref>
,
<xref rid="B4" ref-type="bibr">4</xref>
</sup></p><p>Entre as estrat&#x000e9;gias para auxiliar no manejo da HA est&#x000e3;o as novas tecnologias, como as
<italic toggle="yes">mobile health (mHealth)</italic>
. Em 2022, cerca de 5 bilh&#x000f5;es de pessoas no mundo utilizavam telefone celular com acesso &#x000e0; internet.<sup>
<xref rid="B5" ref-type="bibr">5</xref>
</sup> Observa-se que o uso de aplicativos m&#x000f3;veis na &#x000e1;rea da sa&#x000fa;de vem aumentando de forma acelerada, sendo considerados formas promissoras, de f&#x000e1;cil usabilidade e baixo custo, ou at&#x000e9; mesmo sem custo, para auxiliar no tratamento dos pacientes hipertensos.<sup>
<xref rid="B6" ref-type="bibr">6</xref>
-
<xref rid="B8" ref-type="bibr">8</xref>
</sup></p><p>&#x000c9; esperado que o uso dessa ferramenta promova maior conscientiza&#x000e7;&#x000e3;o dos usu&#x000e1;rios sobre a import&#x000e2;ncia do tratamento, aumento do monitoramento dos n&#x000ed;veis press&#x000f3;ricos, maior ades&#x000e3;o medicamentosa e incentivo a mudan&#x000e7;as de h&#x000e1;bitos de vida. No entanto, apenas uma pequena parcela dos aplicativos voltados para pacientes com HA foi criada por organiza&#x000e7;&#x000f5;es confi&#x000e1;veis, como universidades ou companhias que trabalham diretamente com o manejo dessa comorbidade, o que traz certa preocupa&#x000e7;&#x000e3;o em rela&#x000e7;&#x000e3;o &#x000e0; acur&#x000e1;cia cient&#x000ed;fica do uso dessas tecnologias.<sup>
<xref rid="B6" ref-type="bibr">6</xref>
,
<xref rid="B9" ref-type="bibr">9</xref>
</sup></p><p>Por meio de busca realizada pela plataforma
<italic toggle="yes">Pubmed,</italic>
observa-se um aumento no n&#x000fa;mero de artigos publicados com a palavra-chave
<italic toggle="yes">mHealth,</italic>
de 2284 artigos em 2014 para 8012 em 2024 (Gr&#x000e1;fico 1). A busca realizada com a palavra-chave
<italic toggle="yes">mobile application</italic>
e
<italic toggle="yes">hypertension</italic>
resultou em 9 artigos publicados em 2014 e 92 em 2024 (Gr&#x000e1;fico 2), por&#x000e9;m dentre estes apenas 3 foram publicados tamb&#x000e9;m em portugu&#x000ea;s, o que demonstra que poucos estudos foram realizados com a popula&#x000e7;&#x000e3;o brasileira.</p><p>Johann et al., visando avaliar a qualidade dos aplicativos de smartphones para aux&#x000ed;lio do manejo da HA no cen&#x000e1;rio brasileiro, realizaram o estudo
<italic toggle="yes">An&#x000e1;lise do Conte&#x000fa;do de Aplicativos M&#x000f3;veis Brasileiros Voltados ao Controle da Press&#x000e3;o Arterial: Uma Busca Sistem&#x000e1;tica</italic>
. Essa pesquisa &#x000e9; uma revis&#x000e3;o sistem&#x000e1;tica realizada nas lojas de aplicativos dos sistemas operacionais Android e IOS, sendo uma primeira busca entre 2021 e 2022, com atualiza&#x000e7;&#x000e3;o em 2024.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>A qualidade dos aplicativos foi avaliada pela escala de cinco pontos MARS (
<italic toggle="yes">Mobile App Rating Scale</italic>
), a qual avaliou engajamento, funcionalidade, est&#x000e9;tica e informa&#x000e7;&#x000e3;o, al&#x000e9;m dessa escala foram avaliados aspectos das ferramentas e dos conte&#x000fa;dos sobre a doen&#x000e7;a. Encontraram 56 aplicativos de acordo com os crit&#x000e9;rios pr&#x000e9;-estabelecidos, sendo que a ferramenta mais prevalente foi a de registro de valores de press&#x000e3;o arterial em 98% dos aplicativos, enquanto o registro das medica&#x000e7;&#x000f5;es esteve presente em 29% e lembretes do uso das medica&#x000e7;&#x000f5;es em 34%. A m&#x000e9;dia do escore avaliado MARS foi de 3,4 &#x000b1;0,74 para sistema Android e 3,1&#x000b1;0,61 para sistema IOS, sendo que o item mais bem avaliado foi a funcionalidade.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>O estudo apresenta algumas limita&#x000e7;&#x000f5;es: os aplicativos pagos n&#x000e3;o foram inclu&#x000ed;dos, o que pode corresponder &#x000e0; an&#x000e1;lise apenas das vers&#x000f5;es mais simples, os dispon&#x000ed;veis em ambas as plataformas (Android e iOS) foram analisados em apenas uma delas e as atualiza&#x000e7;&#x000f5;es ou at&#x000e9; desativa&#x000e7;&#x000f5;es durante o ano de 2024 n&#x000e3;o foram relatadas. Embora essas limita&#x000e7;&#x000f5;es possam interferir nos dados obtidos, fica claro que v&#x000e1;rios aplicativos det&#x000ea;m qualidade aceit&#x000e1;vel. O estudo tamb&#x000e9;m aponta necessidade de melhorias, j&#x000e1; que poucos aplicativos inclu&#x000ed;ram fatores importantes com impacto na ades&#x000e3;o medicamentosa, como os lembretes das medica&#x000e7;&#x000f5;es, atividades informativas sobre a doen&#x000e7;a, al&#x000e9;m de medidas de incentivo &#x000e0; mudan&#x000e7;a de estilo de vida e controle de comorbidades.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>O presente estudo ressalta a import&#x000e2;ncia da avalia&#x000e7;&#x000e3;o dos aplicativos m&#x000f3;veis no aumento da ades&#x000e3;o ao tratamento da HA. Fica clara a necessidade de mais estudos que avaliem o quanto o paciente est&#x000e1; empoderado com o uso dos aplicativos, analisando o impacto no esclarecimento acerca da doen&#x000e7;a e na ades&#x000e3;o &#x000e0;s terapias farmacol&#x000f3;gicas e n&#x000e3;o-farmacol&#x000f3;gicas. Por meio do avan&#x000e7;o nas pesquisas, os aplicativos m&#x000f3;veis t&#x000ea;m o potencial de ser uma ferramenta aliada ao profissional de sa&#x000fa;de no tratamento da HA.<sup>
<xref rid="B5" ref-type="bibr">5</xref>
,
<xref rid="B9" ref-type="bibr">9</xref>
,
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><fig position="float" id="f1"><label>Figura 1</label><caption><title>Artigos publicados com a palavra-chave mobile health: 2284 em 2014, com aumento para 8012 artigos em 2024, na plataforma Pubmed. Observa-se expressivo aumento a partir de 2020, possivelmente associado &#x000e0; pandemia por COVID-19, com maior uso de aplicativos m&#x000f3;veis para aux&#x000ed;lio no cuidado em sa&#x000fa;de.</title></caption><graphic xlink:href="0066-782X-abc-122-02-e20250085-gf01" position="float"/></fig><fig position="float" id="f2"><label>Figura 2</label><caption><title>Artigos publicados com a palavra-chave mobile application e hypertension: 9 artigos em 2014, com aumento para 92 artigos em 2024, na plataforma Pubmed</title></caption><graphic xlink:href="0066-782X-abc-122-02-e20250085-gf02" position="float"/></fig></body><back><fn-group><fn fn-type="other" id="fn1"><p><bold>Minieditorial referente ao artigo:</bold> An&#x000e1;lise do Conte&#x000fa;do de Aplicativos M&#x000f3;veis Brasileiros Voltados ao Controle da Press&#x000e3;o Arterial: Uma Busca Sistem&#x000e1;tica</p></fn></fn-group><ref-list><title>Refer&#x000ea;ncias</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barroso</surname><given-names>WKS</given-names></name>
<name><surname>Rodrigues</surname><given-names>CIS</given-names></name>
<name><surname>Bortolotto</surname><given-names>LA</given-names></name>
<name><surname>Mota-Gomes</surname><given-names>MA</given-names></name>
<name><surname>Brand&#x000e3;o</surname><given-names>AA</given-names></name>
<name><surname>Feitosa</surname><given-names>ADM</given-names></name>
<etal/>
</person-group><article-title>Brazilian Guidelines of Hypertension - 2020</article-title><source>
Arq Bras Cardiol
</source><year>2021</year><volume>116</volume><issue>3</issue><fpage>516</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.36660/abc.20201238</pub-id><pub-id pub-id-type="pmid">33909761</pub-id>
</element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de</collab>
</person-group><source>
Vigitel Brasil 2023: Vigil&#x000e2;ncia de Fatores de Risco e Prote&#x000e7;&#x000e3;o para Doen&#x000e7;as Cr&#x000f4;nicas por Inqu&#x000e9;rito Telef&#x000f4;nico: Estimativas sobre Frequ&#x000ea;ncia e Distribui&#x000e7;&#x000e3;o Sociodemogr&#x000e1;fica de Fatores de Risco e Prote&#x000e7;&#x000e3;o para Doen&#x000e7;as Cr&#x000f4;nicas nas Capitais dos 26 Estados Brasileiros e no Distrito Federal em 2023
</source><publisher-loc>Bras&#x000ed;lia</publisher-loc><publisher-name>Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name><year>2023</year></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carvalho</surname><given-names>AS</given-names></name>
<name><surname>Santos</surname><given-names>P</given-names></name>
</person-group><article-title>Medication Adherence in Patients with Arterial Hypertension: The Relationship with Healthcare Systems&#x02019; Organizational Factors</article-title><source>
Patient Prefer Adherence
</source><year>2019</year><volume>13</volume><fpage>1761</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.2147/PPA.S216091</pub-id><pub-id pub-id-type="pmid">31802854</pub-id>
</element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Jover</surname><given-names>V</given-names></name>
<name><surname>Sala-Gonz&#x000e1;lez</surname><given-names>M</given-names></name>
<name><surname>Guilabert</surname><given-names>M</given-names></name>
<name><surname>Mira</surname><given-names>JJ</given-names></name>
</person-group><article-title>Mobile Apps for Increasing Treatment Adherence: Systematic Review</article-title><source>
J Med Internet Res
</source><year>2019</year><volume>21</volume><issue>6</issue><elocation-id>e12505</elocation-id><pub-id pub-id-type="doi">10.2196/12505</pub-id><pub-id pub-id-type="pmid">31215517</pub-id>
</element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>F</given-names></name>
<name><surname>Song</surname><given-names>T</given-names></name>
<name><surname>Yu</surname><given-names>P</given-names></name>
<name><surname>Deng</surname><given-names>N</given-names></name>
<name><surname>Guan</surname><given-names>Y</given-names></name>
<name><surname>Yang</surname><given-names>Y</given-names></name>
<etal/>
</person-group><article-title>Efficacy of an mHealth App to Support Patients&#x02019; Self-Management of Hypertension: Randomized Controlled Trial</article-title><source>
J Med Internet Res
</source><year>2023</year><volume>25</volume><elocation-id>e43809</elocation-id><pub-id pub-id-type="doi">10.2196/43809</pub-id><pub-id pub-id-type="pmid">38113071</pub-id>
</element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Michalakeas</surname><given-names>C</given-names></name>
<name><surname>Katsi</surname><given-names>V</given-names></name>
<name><surname>Soulaidopoulos</surname><given-names>S</given-names></name>
<name><surname>Dilaveris</surname><given-names>P</given-names></name>
<name><surname>Vrachatis</surname><given-names>D</given-names></name>
<name><surname>Lekakis</surname><given-names>I</given-names></name>
<etal/>
</person-group><article-title>Mobile Phones and Applications in the Management of Patients with Arterial Hypertension</article-title><source>
Am J Cardiovasc Dis
</source><year>2020</year><volume>10</volume><issue>4</issue><fpage>419</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">33224593</pub-id>
</element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jamshidnezhad</surname><given-names>A</given-names></name>
<name><surname>Kabootarizadeh</surname><given-names>L</given-names></name>
<name><surname>Hoseini</surname><given-names>SM</given-names></name>
</person-group><article-title>The Effects of Smartphone Applications on Patients Self-Care with Hypertension: A Systematic Review Study</article-title><source>
Acta Inform Med
</source><year>2019</year><volume>27</volume><issue>4</issue><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.5455/aim.2019.27.263-267</pub-id><pub-id pub-id-type="pmid">32055094</pub-id>
</element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Istepanian</surname><given-names>RSH</given-names></name>
</person-group><article-title>Mobile Health (m-Health) in Retrospect: The Known Unknowns</article-title><source>
Int J Environ Res Public Health
</source><year>2022</year><volume>19</volume><issue>7</issue><fpage>3747</fpage><lpage>3747</lpage><pub-id pub-id-type="doi">10.3390/ijerph19073747</pub-id><pub-id pub-id-type="pmid">35409431</pub-id>
</element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahmed</surname><given-names>MI</given-names></name>
<name><surname>Spooner</surname><given-names>B</given-names></name>
<name><surname>Isherwood</surname><given-names>J</given-names></name>
<name><surname>Lane</surname><given-names>M</given-names></name>
<name><surname>Orrock</surname><given-names>E</given-names></name>
<name><surname>Dennison</surname><given-names>A</given-names></name>
</person-group><article-title>A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare</article-title><source>
Cureus
</source><year>2023</year><volume>15</volume><issue>10</issue><elocation-id>e46454</elocation-id><pub-id pub-id-type="doi">10.7759/cureus.46454</pub-id><pub-id pub-id-type="pmid">37927664</pub-id>
</element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johann</surname><given-names>EB</given-names></name>
<name><surname>Baggio</surname><given-names>M</given-names></name>
<name><surname>Pauli</surname><given-names>NA</given-names></name>
<name><surname>Dilli</surname><given-names>A</given-names></name>
<name><surname>Ilkiu</surname><given-names>RT</given-names></name>
<name><surname>Ritti-Dias</surname><given-names>RM</given-names></name>
<etal/>
</person-group><article-title>An&#x000e1;lise do Conte&#x000fa;do de Aplicativos M&#x000f3;veis Brasileiros Voltados ao Controle da Press&#x000e3;o Arterial: Uma Busca Sistem&#x000e1;tica</article-title><source>
Arq Bras Cardiol
</source><year>2025</year><volume>122</volume><issue>2</issue><elocation-id>e20240339</elocation-id><pub-id pub-id-type="doi">10.36660/abc.20240339</pub-id><pub-id pub-id-type="pmid">39936738</pub-id>
</element-citation></ref></ref-list></back><sub-article article-type="translation" id="S1" xml:lang="en"><front-stub><article-id pub-id-type="doi">10.36660/abc.20250085i</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Editorial</subject></subj-group></article-categories><title-group><article-title>Technologies for Better Blood Pressure Control: Do the Applications Offer the Necessary Quality?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1582-7268</contrib-id><name><surname>Miranda</surname><given-names>Roberto Dischinger</given-names></name><xref rid="aff2" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c2" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-9895-3056</contrib-id><name><surname>Laurindo</surname><given-names>Bruna de Oliveira</given-names></name><xref rid="aff2" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-2921-1559</contrib-id><name><surname>Licco</surname><given-names>Maria Eduarda Augusto</given-names></name><xref rid="aff2" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff2">
<label>1</label>
<addr-line>
<named-content content-type="city">S&#x000e3;o Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Servi&#x000e7;o de Cardiologia, Disciplina de Geriatria e Gerontologia, Escola Paulista de Medicina da Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP &#x02013; Brazil</institution>
</aff></contrib-group><author-notes><corresp id="c2">
<label>Mailing Address:</label>
<bold>Roberto Dischinger Miranda</bold>
&#x02022; Servi&#x000e7;o de Cardiologia, Disciplina de Geriatria e Gerontologia, Escola Paulista de Medicina da Universidade Federal de S&#x000e3;o Paulo - R. dos Otonis, 863. Postal Code
<postal-code>04025-002</postal-code>
, S&#x000e3;o Paulo, SP - Brazil E-mail:
<email>roberto.miranda@institutolongevita.com.br</email>
</corresp></author-notes><kwd-group><title>Keywords</title><kwd>Mobile Applications</kwd><kwd>Technology</kwd><kwd>Smartphone</kwd><kwd>Hypertension</kwd><kwd>Essential Hypertension</kwd><kwd>Medication Adherence</kwd></kwd-group></front-stub><body><p>Chronic diseases are highly prevalent among the Brazilian adult population, with a tendency to increase in the coming years, mainly due to population aging. Among them, systemic arterial hypertension (AH) stands out, affecting Around 27.9% of Brazilians. This condition is the main modifiable risk factor for cardiovascular disease, chronic kidney disease, and premature death, and in 2021, the mortality rate from hypertension reached the highest value in the last ten years, with 18.7 deaths per 100,000 inhabitants.<sup>
<xref rid="B1" ref-type="bibr">1</xref>
,
<xref rid="B2" ref-type="bibr">2</xref>
</sup></p><p>Among the challenges in controlling hypertension is the fact that it is an asymptomatic condition, which makes it difficult to adhere to treatment, which includes lifestyle changes and regular use of antihypertensive medications. It is estimated that, among hypertensive patients, less than half use their medications properly, and poor medication adherence has been declared a public health problem by the World Health Organization. Among the causes of poor adherence are the reported lack of health education, lack of perception of improvement with the use of medication, the occurrence of adverse effects, and forgetting about the use of medications.<sup>
<xref rid="B3" ref-type="bibr">3</xref>
,
<xref rid="B4" ref-type="bibr">4</xref>
</sup></p><p>Among the strategies to assist in the management of AH are new technologies, such as mobile health (mHealth). In 2022, around 5 billion people in the world used cell phones with internet access.<sup>
<xref rid="B5" ref-type="bibr">5</xref>
</sup>It is observed that the use of mobile applications in the health area has been increasing rapidly, being considered promising ways, easy to use and low cost, or even free, to assist in the treatment of hypertensive patients.<sup>
<xref rid="B6" ref-type="bibr">6</xref>
-
<xref rid="B8" ref-type="bibr">8</xref>
</sup></p><p>The use of this tool is expected to promote greater user awareness of the importance of treatment, increased monitoring of blood pressure levels, greater medication adherence, and encourage changes in lifestyle habits. However, only a small portion of the applications aimed at patients with hypertension were created by reliable organizations, such as universities or companies that work directly with the management of this comorbidity, which raises some concerns regarding the scientific accuracy of the use of these technologies.<sup>
<xref rid="B6" ref-type="bibr">6</xref>
,
<xref rid="B9" ref-type="bibr">9</xref>
</sup></p><p>Through a search carried out on the Pubmed platform, an increase in the number of articles published with the keyword mHealth was observed, from 2,284 articles in 2014 to 8,012 in 2024 (
<xref rid="f3" ref-type="fig">Figure 1</xref>
). The search carried out with the keywords mobile application, and hypertension resulted in 9 articles published in 2014 and 92 in 2024 (
<xref rid="f4" ref-type="fig">Figure 2</xref>
), but of these, only 3 were also published in Portuguese, which demonstrates that few studies have been carried out with the Brazilian population.</p><fig position="float" id="f3"><label>Figure 1</label><caption><title>Articles published with the keyword mobile health: 2,284 in 2014, increasing to 8,012 articles in 2024, on the Pubmed platform. A significant increase has been observed since 2020, possibly associated with the COVID-19 pandemic, with greater use of mobile applications to assist in health care.</title></caption><graphic xlink:href="0066-782X-abc-122-02-e20250085-en-gf01" position="float"/></fig><fig position="float" id="f4"><label>Figure 2</label><caption><title>Articles published with the keyword mobile application and hypertension: 9 articles in 2014, increasing to 92 articles in 2024, on the Pubmed platform.</title></caption><graphic xlink:href="0066-782X-abc-122-02-e20250085-en-gf02" position="float"/></fig><p>Johann E. et al., aiming to evaluate the quality of smartphone applications to assist in the management of hypertension in the Brazilian scenario, carried out the study
<italic toggle="yes">Content Analysis of Brazilian Mobile Applications Targeting Blood Pressure Management: A Systematic Search</italic>
. This research is a systematic review carried out in the application stores of the Android and iOS operating systems, with an initial search between 2021 and 2022, with an update in 2024.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>The quality of the applications was assessed using the five-point MARS (Mobile App Rating Scale), which assessed engagement, functionality, aesthetics, and information. In addition, this scale assessed aspects of the tools and content about the disease. They found 56 applications that met the pre-established criteria, with the most prevalent tool being the recording of blood pressure values in 98% of the applications, while the recording of medications was present in 29% and reminders of medication use in 34%. The average MARS score assessed was 3.4.&#x000b1;0.74 for the Android system and 3.1&#x000b1;0.61 for the IOS system, with the best-rated item being functionality.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>The study has some limitations: paid applications were not included, which may correspond to the analysis of only the simplest versions; those available on both platforms (Android and iOS) were analyzed on only one of them; and updates or even deactivations during the year 2024 were not reported. Although these limitations may interfere with the data obtained, it is clear that several applications have acceptable quality. The study also points to the need for improvements since few applications included important factors that impact medication adherence, such as medication reminders, informational activities about the disease, as well as measures to encourage lifestyle changes and control comorbidities.<sup>
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p><p>This study highlights the importance of evaluating mobile applications in increasing adherence to treatment for hypertension. There is a clear need for further studies to assess how much patients are empowered by using applications, analyzing the impact on information about the disease, and adherence to pharmacological and non-pharmacological therapies. Through advances in research, mobile applications have the potential to be a tool that healthcare professionals can use in the treatment of hypertension.<sup>
<xref rid="B5" ref-type="bibr">5</xref>
,
<xref rid="B9" ref-type="bibr">9</xref>
,
<xref rid="B10" ref-type="bibr">10</xref>
</sup></p></body><back><fn-group><fn fn-type="other" id="fn2"><p><bold>Short Editorial related to the article:</bold> Content Analysis of Brazilian Mobile Applications Targeting Blood Pressure Management: A Systematic Search</p></fn></fn-group></back></sub-article></article>